RMEI Continuing Medical Education Infectious Disease

Infectious Disease CE Activities

Optimal Management of Nontuberculous Mycobacterial Lung Disease: A Clinical Olympics Proceedings

1.00 CE Credit(s)

Creating a Pathway to Identify and Treat Influenza in Pediatric Patients

0.5 CE Credit(s)

Utilizing a CDST for Resistant/Refractory CMV in Hematopoietic Cell Transplant Patients

0.5 CE Credit(s)

Optimizing Treatment of Resistant/Refractory CMV Infection in Solid Organ Transplant Recipients

0.75 CE Credit(s)

RMEI DECISION SUPPORT AIDS

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.

Infectious Disease, Pulmonology
Decision Support Aid

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.

Infectious Disease, Pulmonology
Decision Support Aid

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

Infectious Disease
Decision Support Aid

LATEST INFECTIOUS DISEASE ARTICLES

Latest Infectious Disease Articles

Integrating Public Health and Health Care — Protecting Health as a Team Sport May 16, 2024
Protecting health is a team sport — yet the public health and clinical care systems meant to advance this goal have been siloed for too long.
Charlene A. Wong, Debra Houry, Mandy K. Cohen
Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders May 16, 2024
The antibody that mediates the occurrence of VITT associated with adenoviral-based Covid-19 vaccines is nearly identical to the antibodies produced in response to natural adenoviral infection.
Jing Jing Wang, Linda Schönborn, Theodore E. Warkentin, Tim Chataway, Leonie Grosse, Paolo Simioni, Stephan Moll, Andreas Greinacher, Tom P. Gordon
Lymphatic Filariasis May 9, 2024
A 72-year-old man who had emigrated from Zimbabwe 20 years previously presented with a 17-year history of swelling of the penis, scrotum, and left leg.
Matiar Madanchi, Peter Itin

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021